Immunohistochemical Expression of Ki67 and p53 in Primary Breast Carcinoma and Combined Ki67-p53 Status Phenotypes in Hormone Receptor Positive Breast Carcinoma
Introduction: The conventional Immunohistochemical (IHC) biomarkers used to assess breast cancer patients include Hormone Receptor (HR) status and HER2 status. IHC analysis of Ki67 is useful to stratify the HR-positive tumours into good and bad prognosis categories; p53-status can identify patients...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2020-03-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/13581/43546_F(SL)_CE[Ra1]_(SL)_PF1(ShG_KM)_PN(SL).pdf |